A
Apollo Endosurgery Inc
F:HQ8F
Apollo Endosurgery Inc
F:HQ8F
Price:
9.1
EUR
1.09%
Market Cap:
€432.7m
Relative Value
There is not enough data to reliably calculate the relative value of HQ8F.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
HQ8F
Relative Value
Base Case
Not Available
Multiples Across Competitors
HQ8F Competitors Multiples
Apollo Endosurgery Inc Competitors
Apollo Endosurgery Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
A
|
Apollo Endosurgery Inc
F:HQ8F
|
432.7m EUR | 6.6 | -12.8 | -19.6 | -17.5 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
196.4B USD | 4.4 | 29.7 | 17 | 23.4 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
177.6B USD | 17.7 | 62.3 | 47.3 | 58.1 | |
| US |
|
Stryker Corp
NYSE:SYK
|
146.1B USD | 5.7 | 44.4 | 22.5 | 27.2 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
121.1B USD | 3.4 | 26.2 | 14.3 | 20.8 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
106.7B USD | 5.3 | 36.9 | 21.6 | 29 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
45.6B EUR | 2 | 21.6 | 11.9 | 16.8 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
50.1B USD | 11.7 | 47.5 | 33.7 | 37.3 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
48.9B USD | 8.1 | 45.6 | 25.1 | 27.5 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
48.8B USD | 2.2 | 27.4 | 10.6 | 18 | |
| US |
|
Resmed Inc
NYSE:RMD
|
37.7B USD | 6.9 | 25.2 | 17.8 | 19.8 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
